Cargando…

Primary effusion lymphoma enhancer connectome links super-enhancers to dependency factors

Primary effusion lymphoma (PEL) has a very poor prognosis. To evaluate the contributions of enhancers/promoters interactions to PEL cell growth and survival, here we produce H3K27ac HiChIP datasets in PEL cells. This allows us to generate the PEL enhancer connectome, which links enhancers and promot...

Descripción completa

Detalles Bibliográficos
Autores principales: Wang, Chong, Zhang, Luyao, Ke, Liangru, Ding, Weiyue, Jiang, Sizun, Li, Difei, Narita, Yohei, Hou, Isabella, Liang, Jun, Li, Shijun, Xiao, Haipeng, Gottwein, Eva, Kaye, Kenneth M., Teng, Mingxiang, Zhao, Bo
Formato: Online Artículo Texto
Lenguaje:English
Publicado: Nature Publishing Group UK 2020
Materias:
Acceso en línea:https://www.ncbi.nlm.nih.gov/pmc/articles/PMC7726151/
https://www.ncbi.nlm.nih.gov/pubmed/33298918
http://dx.doi.org/10.1038/s41467-020-20136-w
_version_ 1783620823976771584
author Wang, Chong
Zhang, Luyao
Ke, Liangru
Ding, Weiyue
Jiang, Sizun
Li, Difei
Narita, Yohei
Hou, Isabella
Liang, Jun
Li, Shijun
Xiao, Haipeng
Gottwein, Eva
Kaye, Kenneth M.
Teng, Mingxiang
Zhao, Bo
author_facet Wang, Chong
Zhang, Luyao
Ke, Liangru
Ding, Weiyue
Jiang, Sizun
Li, Difei
Narita, Yohei
Hou, Isabella
Liang, Jun
Li, Shijun
Xiao, Haipeng
Gottwein, Eva
Kaye, Kenneth M.
Teng, Mingxiang
Zhao, Bo
author_sort Wang, Chong
collection PubMed
description Primary effusion lymphoma (PEL) has a very poor prognosis. To evaluate the contributions of enhancers/promoters interactions to PEL cell growth and survival, here we produce H3K27ac HiChIP datasets in PEL cells. This allows us to generate the PEL enhancer connectome, which links enhancers and promoters in PEL genome-wide. We identify more than 8000 genomic interactions in each PEL cell line. By incorporating HiChIP data with H3K27ac ChIP-seq data, we identify interactions between enhancers/enhancers, enhancers/promoters, and promoters/promoters. HiChIP further links PEL super-enhancers to PEL dependency factors MYC, IRF4, MCL1, CCND2, MDM2, and CFLAR. CRISPR knock out of MEF2C and IRF4 significantly reduces MYC and IRF4 super-enhancer H3K27ac signal. Knock out also reduces MYC and IRF4 expression. CRISPRi perturbation of these super-enhancers by tethering transcription repressors to enhancers significantly reduces target gene expression and reduces PEL cell growth. These data provide insights into PEL molecular pathogenesis.
format Online
Article
Text
id pubmed-7726151
institution National Center for Biotechnology Information
language English
publishDate 2020
publisher Nature Publishing Group UK
record_format MEDLINE/PubMed
spelling pubmed-77261512020-12-17 Primary effusion lymphoma enhancer connectome links super-enhancers to dependency factors Wang, Chong Zhang, Luyao Ke, Liangru Ding, Weiyue Jiang, Sizun Li, Difei Narita, Yohei Hou, Isabella Liang, Jun Li, Shijun Xiao, Haipeng Gottwein, Eva Kaye, Kenneth M. Teng, Mingxiang Zhao, Bo Nat Commun Article Primary effusion lymphoma (PEL) has a very poor prognosis. To evaluate the contributions of enhancers/promoters interactions to PEL cell growth and survival, here we produce H3K27ac HiChIP datasets in PEL cells. This allows us to generate the PEL enhancer connectome, which links enhancers and promoters in PEL genome-wide. We identify more than 8000 genomic interactions in each PEL cell line. By incorporating HiChIP data with H3K27ac ChIP-seq data, we identify interactions between enhancers/enhancers, enhancers/promoters, and promoters/promoters. HiChIP further links PEL super-enhancers to PEL dependency factors MYC, IRF4, MCL1, CCND2, MDM2, and CFLAR. CRISPR knock out of MEF2C and IRF4 significantly reduces MYC and IRF4 super-enhancer H3K27ac signal. Knock out also reduces MYC and IRF4 expression. CRISPRi perturbation of these super-enhancers by tethering transcription repressors to enhancers significantly reduces target gene expression and reduces PEL cell growth. These data provide insights into PEL molecular pathogenesis. Nature Publishing Group UK 2020-12-09 /pmc/articles/PMC7726151/ /pubmed/33298918 http://dx.doi.org/10.1038/s41467-020-20136-w Text en © The Author(s) 2020 Open Access This article is licensed under a Creative Commons Attribution 4.0 International License, which permits use, sharing, adaptation, distribution and reproduction in any medium or format, as long as you give appropriate credit to the original author(s) and the source, provide a link to the Creative Commons license, and indicate if changes were made. The images or other third party material in this article are included in the article’s Creative Commons license, unless indicated otherwise in a credit line to the material. If material is not included in the article’s Creative Commons license and your intended use is not permitted by statutory regulation or exceeds the permitted use, you will need to obtain permission directly from the copyright holder. To view a copy of this license, visit http://creativecommons.org/licenses/by/4.0/.
spellingShingle Article
Wang, Chong
Zhang, Luyao
Ke, Liangru
Ding, Weiyue
Jiang, Sizun
Li, Difei
Narita, Yohei
Hou, Isabella
Liang, Jun
Li, Shijun
Xiao, Haipeng
Gottwein, Eva
Kaye, Kenneth M.
Teng, Mingxiang
Zhao, Bo
Primary effusion lymphoma enhancer connectome links super-enhancers to dependency factors
title Primary effusion lymphoma enhancer connectome links super-enhancers to dependency factors
title_full Primary effusion lymphoma enhancer connectome links super-enhancers to dependency factors
title_fullStr Primary effusion lymphoma enhancer connectome links super-enhancers to dependency factors
title_full_unstemmed Primary effusion lymphoma enhancer connectome links super-enhancers to dependency factors
title_short Primary effusion lymphoma enhancer connectome links super-enhancers to dependency factors
title_sort primary effusion lymphoma enhancer connectome links super-enhancers to dependency factors
topic Article
url https://www.ncbi.nlm.nih.gov/pmc/articles/PMC7726151/
https://www.ncbi.nlm.nih.gov/pubmed/33298918
http://dx.doi.org/10.1038/s41467-020-20136-w
work_keys_str_mv AT wangchong primaryeffusionlymphomaenhancerconnectomelinkssuperenhancerstodependencyfactors
AT zhangluyao primaryeffusionlymphomaenhancerconnectomelinkssuperenhancerstodependencyfactors
AT keliangru primaryeffusionlymphomaenhancerconnectomelinkssuperenhancerstodependencyfactors
AT dingweiyue primaryeffusionlymphomaenhancerconnectomelinkssuperenhancerstodependencyfactors
AT jiangsizun primaryeffusionlymphomaenhancerconnectomelinkssuperenhancerstodependencyfactors
AT lidifei primaryeffusionlymphomaenhancerconnectomelinkssuperenhancerstodependencyfactors
AT naritayohei primaryeffusionlymphomaenhancerconnectomelinkssuperenhancerstodependencyfactors
AT houisabella primaryeffusionlymphomaenhancerconnectomelinkssuperenhancerstodependencyfactors
AT liangjun primaryeffusionlymphomaenhancerconnectomelinkssuperenhancerstodependencyfactors
AT lishijun primaryeffusionlymphomaenhancerconnectomelinkssuperenhancerstodependencyfactors
AT xiaohaipeng primaryeffusionlymphomaenhancerconnectomelinkssuperenhancerstodependencyfactors
AT gottweineva primaryeffusionlymphomaenhancerconnectomelinkssuperenhancerstodependencyfactors
AT kayekennethm primaryeffusionlymphomaenhancerconnectomelinkssuperenhancerstodependencyfactors
AT tengmingxiang primaryeffusionlymphomaenhancerconnectomelinkssuperenhancerstodependencyfactors
AT zhaobo primaryeffusionlymphomaenhancerconnectomelinkssuperenhancerstodependencyfactors